Table 3 Distribution of study patients according to drug treatment
From: Epidemiology and long-term prognosis of atrial fibrillation in rural African patients
Drug | Value |
|---|---|
Antiarrhythmics | |
Amiodarone, n (%) | 31 (30.69) |
Betablockers, n (%) | 17 (16.83) |
Digoxin, n (%) | 40 (39.60) |
Calcium channel blockers, n (%) | 02 (1.98) |
Amiodarone + digoxin, n (%) | 11 (10.89) |
Antithrombotics | |
Enoxaparin, n (%) | 25 (24.75) |
Vitamin K antagonist*, n (%) | 4 (5.26) |
Antiplatelet agents, n (%) | 84 (83.17) |
ACEI/ARB, n (%) | 94 (93.07) |
Spironolactone, n (%) | 63 (62.38) |
Thiazides, n (%) | 9 (8.91) |
Loop diuretics, n (%) | 86 (85.15) |
Nitrates, n (%) | 55 (54.46) |
Statins, n (%) | 6 (5.94) |